These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23144892)

  • 1. MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.
    Testa JS; Shetty V; Hafner J; Nickens Z; Kamal S; Sinnathamby G; Philip R
    PLoS One; 2012; 7(11):e48484. PubMed ID: 23144892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the affinity of influenza A virus protein epitopes for swine MHC I by a modified in vitro refolding method indicated cross-reactivity between swine and human MHC I specificities.
    Fan S; Wang Y; Wang X; Huang L; Zhang Y; Liu X; Zhu W
    Immunogenetics; 2018 Nov; 70(10):671-680. PubMed ID: 29992375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies.
    Keating R; Johnson JL; Brice DC; Labombarde JG; Dent AL; McGargill MA
    mBio; 2020 Nov; 11(6):. PubMed ID: 33144374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
    Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
    J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
    Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
    Price GE; Ou R; Jiang H; Huang L; Moskophidis D
    J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
    Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.
    Testa JS; Shetty V; Sinnathamby G; Nickens Z; Hafner J; Kamal S; Zhang X; Jett M; Philip R
    J Infect Dis; 2012 Feb; 205(4):647-55. PubMed ID: 22246683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
    Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
    J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.
    Zhong W; Liu F; Dong L; Lu X; Hancock K; Reinherz EL; Katz JM; Sambhara S
    PLoS One; 2010 May; 5(5):e10583. PubMed ID: 20485501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.
    Fan S; Wu Y; Wang S; Wang Z; Jiang B; Liu Y; Liang R; Zhou W; Zhang N; Xia C
    J Virol; 2016 Aug; 90(15):6625-6641. PubMed ID: 27170754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.
    Choo JA; Liu J; Toh X; Grotenbreg GM; Ren EC
    J Virol; 2014 Sep; 88(18):10613-23. PubMed ID: 24990997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
    Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
    Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly conserved influenza T cell epitopes induce broadly protective immunity.
    Eickhoff CS; Terry FE; Peng L; Meza KA; Sakala IG; Van Aartsen D; Moise L; Martin WD; Schriewer J; Buller RM; De Groot AS; Hoft DF
    Vaccine; 2019 Aug; 37(36):5371-5381. PubMed ID: 31331771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
    Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
    PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.
    Alam S; Sant AJ
    J Virol; 2011 Dec; 85(24):13310-21. PubMed ID: 21976658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
    Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
    J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
    Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
    J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.